Cargando…
Randomized and non-randomized designs for causal inference with longitudinal data in rare disorders
In the United States, approximately 7000 rare diseases affect 30 million patients, and only 10% of these diseases have existing therapies. Sound study design and causal inference methods are essential to demonstrate the therapeutic efficacy, safety, and effectiveness of new therapies. In the rare di...
Autores principales: | Izem, Rima, McCarter, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609847/ https://www.ncbi.nlm.nih.gov/pubmed/34814939 http://dx.doi.org/10.1186/s13023-021-02124-5 |
Ejemplares similares
-
Novel clinical trial design and analytic methods to tackle challenges in therapeutic development in rare diseases
por: Li, Yimei, et al.
Publicado: (2022) -
Regression Discontinuity Designs in Epidemiology: Causal Inference Without Randomized Trials
por: Bor, Jacob, et al.
Publicado: (2014) -
Application of Causal Inference Methods to Pooled Longitudinal Non- Randomized Studies: A Methodological Systematic Review
por: Hufstedler, Heather, et al.
Publicado: (2023) -
Mendelian randomization analyses in ocular disease: a powerful approach to causal inference with human genetic data
por: Li, Jiaxin, et al.
Publicado: (2022) -
Addressing missing data in randomized clinical trials: A causal inference perspective
por: Cornelisz, Ilja, et al.
Publicado: (2020)